Roivant Sciences Ltd’s recently made public that its 10% Owner Ramaswamy Vivek unloaded Company’s shares for reported $43.39 million on Dec 12 ’25. In the deal valued at $21.96 per share,1,975,858 shares were sold. As a result of this transaction, Ramaswamy Vivek now holds 36,350,621 shares worth roughly $833.88 million.
Then, Ramaswamy Vivek sold 774,142 shares, generating $16,752,433 in total proceeds. Upon selling the shares at $21.64, the 10% Owner now owns 34,749,305 shares.
Before that, Ramaswamy Vivek sold 353,745 shares. Roivant Sciences Ltd shares valued at $7,800,077 were divested by the 10% Owner at a price of $22.05 per share. As a result of the transaction, Ramaswamy Vivek now holds 34,132,463 shares, worth roughly $783.0 million.
Citigroup initiated its Roivant Sciences Ltd [ROIV] rating to a Buy in a research note published on September 02, 2025; the price target was $16. Wolfe Research began covering ROIV with “an Outperform” recommendation on February 15, 2024. Piper Sandler started covering the stock on January 05, 2024. It rated ROIV as “an Overweight”.
Price Performance Review of ROIV
On Tuesday, Roivant Sciences Ltd [NASDAQ:ROIV] saw its stock jump 4.75% to $22.94. Over the last five days, the stock has gained 12.29%. Roivant Sciences Ltd shares have risen nearly 93.10% since the year began. Nevertheless, the stocks have risen 93.91% over the past one year. While a 52-week high of $22.56 was reached on 12/16/25, a 52-week low of $8.73 was recorded on 04/07/25.
Levels Of Support And Resistance For ROIV Stock
The 24-hour chart illustrates a support level at 22.08, which if violated will result in even more drops to 21.23. On the upside, there is a resistance level at 23.51. A further resistance level may holdings at 24.08.
How much short interest is there in Roivant Sciences Ltd?
A steep rise in short interest was recorded in Roivant Sciences Ltd stocks on 2025-11-28, dropping by -3.61 million shares to a total of 20.91 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 24.53 million shares. There was a decline of -17.28%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 12, 2023 when Deutsche Bank began covering the stock and recommended ‘”a Buy”‘ rating along with a $14 price target.
